BERNS PAUL L 13D and 13G filings for Neumora Therapeutics, Inc. Common Stock:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-13 4:30 pm Purchase | 2024-12-31 | 13G | Neumora Therapeutics, Inc. Common Stock NMRA | BERNS PAUL L | 8,226,272 5.100% | 242,125 (+3.03%) | Filing |
| 2024-02-14 4:17 pm Purchase | 2023-12-31 | 13G | Neumora Therapeutics, Inc. Common Stock NMRA | BERNS PAUL L | 7,984,147 5.200% | 7,984,147 (New Position) | Filing |